SIRT3 affects one carbon metabolism by promoting the activity of serine hydroxy methyltransferase 2 (SHMT2), whose overexpression is linked to poorer prognosis for CRC patients, thus triggering cell proliferation and growth [110]. The gene discussed is SHMT2; the disease is colorectal carcinoma.